Long-term results of treatment with bosentan in adult Eisenmenger’s syndrome patients with Down’s syndrome related to congenital heart disease

BACKGROUND: Patients with Down’s syndrome and shunt lesions are at high risk of developing pulmonary arterial hypertension (PAH) earlier than patients without Down’s syndrome. However, data on the efficacy of PAH-specific therapy in patients with Down’s syndrome are limited. The aim of this retrospe...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Crepaz, Roberto, Romeo, Cristina, Montanaro, Donato, De Santis, Stefano
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848635/
https://ncbi.nlm.nih.gov/pubmed/24047157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-13-74
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky